Tailoring AI Solutions for Health Care Needs
AI is rapidly reshaping health care, with the FDA approving more than 1,300 AI‑enabled medical devices—over half in the past three years—and a surge in non‑device AI for administrative tasks. Mayo Clinic Platform stresses that successful tools must blend deep clinical insight with technical rigor, otherwise adoption stalls. A recent survey shows 72% of technology leaders prioritize AI that eases caregiver burden, while 61% plan partnerships with third‑party vendors for custom generative AI solutions. Immature tools remain a major barrier, cited by 77% of providers.
Needle-Free Diabetes Care: 6 Devices that Painlessly Monitor Blood Sugar
Needle‑free glucose monitors are moving from research labs to commercial shelves, with six innovative devices highlighted for their non‑invasive approaches. Abbott’s FreeStyle Libre remains the market leader for interstitial sensing, while newcomers such as Occuity Indigo, D‑Pocket, Light Touch Technology,...
In India, Medical Titles Debate Raises Public Health Concerns
India’s Kerala High Court ruled that physiotherapists and occupational therapists may use the prefix “Dr.” provided they add the suffix “PT,” a decision formalized in the 2025 Competency‑Based Curriculum for Physiotherapy. The ruling sparked sharp opposition from the Indian Medical...
The Current State of the Physician Workforce: 9 Notes
The Health Resources and Services Administration projects a shortfall of 141,160 full‑time‑equivalent physicians by 2038, underscoring a deepening workforce gap. Hospital systems are increasingly recruiting without higher salaries, emphasizing culture, autonomy and personalized outreach. Visa processing delays have sidelined over...
BioCryst Partners with Irish Affiliate of Neopharmed Gentili in ~$345M EU Commercialization Deal for Navenibart
BioCryst Pharmaceuticals has signed a licensing agreement with the Irish affiliate of Neopharmed Gentili, granting exclusive rights to commercialize its long‑acting plasma kallikrein inhibitor, Navenibart, across the European Union. The deal provides BioCryst with a $70 million upfront payment and potential...
Regulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned - 09/23/2025
In a September 23, 2025 speech, FDA Principal Deputy Commissioner Sara Brenner outlined how real‑world evidence (RWE) has been used to support regulatory decisions and announced the agency‑wide FDA‑RWE‑ACCELERATE initiative. She highlighted recent examples from CDER, CBER and CDRH, and introduced Sentinel 3.0,...
Dana-Farber Mega-Deal Pays for Cancer Center and Refunding
Dana‑Farber Cancer Institute issued $1.4 billion of municipal revenue bonds (Series Q and R) to fund half of a new 300‑bed cancer‑hospital tower and to refinance nearly all existing debt. The first tranche of $1.304 billion carries yields from 3.57% to 4.84% and...
Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
Sonire Therapeutics announced the launch of SUNRISE‑II, its first U.S. clinical trial evaluating a proprietary high‑intensity focused ultrasound (HIFU) system for pancreatic cancer. The study will enroll roughly 10 patients to assess safety and feasibility. The inaugural patient was treated...
Using AI to Anticipate Healthcare Air Quality Risks
Healthcare facilities are turning to AI‑driven air‑quality platforms to move from reactive monitoring to predictive protection. By fusing IoT sensor streams with machine‑learning models, systems like SensusAir can forecast spikes in pathogens, humidity or chemical pollutants hours before they endanger...
Center for Drug Evaluation and Research Organization Chart
The U.S. Food and Drug Administration has published an updated Center for Drug Evaluation and Research (CDER) organization chart effective May 1 2026. The visual diagram outlines the current leadership hierarchy, reporting lines, and functional units overseeing drug regulation. Accompanying the image...
Novel In-Hospital Screening Method Detects Cognitive Issues
Cedars‑Sinai investigators introduced a multicomponent in‑hospital screening that combines brief nursing assessments with an electronic health‑record algorithm to identify cognitive impairment and dementia in patients over 65. In a rollout covering more than 11,000 admissions, the program screened over 80%...
Here's How Medication Abortion Works with Just One Drug That's Still Fully Available
A federal appeals court ordered the FDA to revert to in‑person prescribing rules for mifepristone, overturning the Biden administration’s telehealth flexibility. The decision takes effect nationwide, while the makers of mifepristone have appealed to the Supreme Court for a rapid...
OpenAI Made a Special ChatGPT for Your Doctor
OpenAI unveiled ChatGPT for Clinicians, a free, HIPAA‑compliant AI assistant built on its GPT‑5.4 model and tailored with health‑specific tools. The service targets doctors, nurses, physician assistants and pharmacists, pulling answers from peer‑reviewed studies, clinical guidelines and public‑health guidance. In...
Celcuity Reports the P-III (VIKTORIA-1) Trial Data on Gedatolisib Combination for HR+/HER2- PIK3CA Mutant Advanced Breast Cancer
Celcuity announced phase‑III VIKTORIA‑1 data showing that gedatolisib combined with fulvestrant, with or without palbociclib, achieved a statistically significant improvement in progression‑free survival (PFS) versus the alpelisib‑fulvestrant standard of care in HR+/HER2‑ advanced breast cancer patients harboring PIK3CA mutations. The...
The Power of Real World Data to Study Women’s Health at Scale
Veradigm released its 2026 Women’s Health Report, leveraging real‑world evidence from its network of electronic health records linked to claims data. The report maps health trends across adolescence, reproductive years, and peri/post‑menopause, highlighting disease risk, comorbidities, and treatment patterns unique...
Beyond Concierge Medicine: The Rise of Retained Health Management for Founders
Brad Pierce, co‑founder of Human Sync, argues that founders treat their bodies like an unmanaged asset, relying on annual physicals or concierge medicine that only speed access. He proposes a retained health‑management model that continuously monitors biomarkers, genetics and performance,...
Drugmaker AbbVie Chooses North Carolina for $1.4B Manufacturing Campus
AbbVie announced a $1.4 billion investment to build a 185‑acre manufacturing campus in Durham, North Carolina, targeting its immunology, neuroscience and oncology portfolios. The site will create 734 jobs over four years, incorporate AI‑driven production tools, and be operational by the...
Use of Hepatitis C-Positive Donors Reduces Pancreas Transplant Wait Times
Researchers at Cedars‑Sinai Health Sciences found that using hepatitis C‑positive pancreas donors slashes wait times by an average of 117 days. The study, published in the American Journal of Transplantation, shows that recipients of HCV‑positive organs enjoy comparable graft function and...
Murata Ramps up Ultra-Low Power AMR Sensor Output for Wearable and IoT Use
Murata Manufacturing has started mass production of two ultra‑low power anisotropic magnetoresistance (AMR) sensors, the MRMS166R and MRMS168R, aimed at wearables, healthcare devices, and IoT applications. The MRMS166R draws only about 20 nA at 1.2 V, enabling standby periods of over two...
Seeing Keratoconus Earlier with Light Polarization and AI
Researchers combined polarization‑sensitive optical coherence tomography (PS‑OCT) with artificial‑intelligence algorithms to improve detection of subclinical keratoconus. In a study of 359 eyes from Narayana Nethralaya, the PS‑OCT‑based model outperformed conventional shape‑based devices such as Pentacam and MS‑39 in identifying early...
Solving the $150B No-Show Problem: The Rise of Healthcare Conversation Intelligence
Healthcare providers lose up to $150 billion a year to missed appointments, a problem that persists despite the phone’s central role in patient access. Conversation intelligence—AI‑driven analysis of call content, sentiment, and outcomes—turns unstructured voice data into scalable insights. By flagging...
How a Vision-Restoring Gene Therapy Proved that We Can Treat Inherited Diseases
Luxturna, the first FDA‑approved gene‑augmenting therapy for inherited retinal disease, received the 2026 Breakthrough Prize after restoring sight to patients with Leber’s congenital amaurosis type 2. Developed by Spark Therapeutics founders Katherine High, Jean Bennett and surgeon Albert Maguire, the treatment...
Obesity Ends Oncology’s Long Reign as Top Contributor to Biopharma Pipeline Value
Deloitte’s 2025 pipeline analysis shows obesity overtaking oncology as the top value‑generating therapeutic area, accounting for 25% of total pipeline worth. Eli Lilly and Novo Nordisk dominate the obesity segment, together holding roughly 96% of its assigned value. GLP‑1/GIP agonists are driving...
The Federal Government Didn’t Legalize Marijuana. Here’s What Actually Changed.
On April 23 the Justice Department reclassified state‑licensed and FDA‑approved medical marijuana products from Schedule I to Schedule III. The move does not legalize cannabis federally but opens the door for tax deductions, retroactive refunds, and fewer research barriers. It signals a...
Express Delegation Still Means What It Says: Sixth Circuit Upholds DOL Home Care Rule After Loper Bright
On April 1 2026 the Sixth Circuit upheld the Department of Labor’s 2013 rule that requires third‑party home‑care agencies to pay overtime, even for live‑in caregivers caring for family members. The court ruled that Congress’s express delegation of authority to the DOL...
Should a California Union Dictate How Clinics Spend Money? Employers Sue to Block Ballot Measure
The Service Employees International Union‑United Healthcare Workers West (SEIU‑UHW) has qualified the Clinic Funding Accountability and Transparency Act for the November ballot after gathering more than one million signatures. The initiative would require federally qualified health centers to spend at...
FDA Grants 510(k) Clearance to TaeWoong Medical for Spaxus EUS Stent
TaeWoong Medical received FDA 510(k) clearance for its Niti‑S Spaxus Stent, a fully covered, self‑expanding metallic device used in endoscopic ultrasound (EUS)‑guided drainage. The stent is approved for draining symptomatic pancreatic pseudocysts, walled‑off necrosis larger than 6 cm, and for gallbladder...
What Doctors Want You to Know About Cannabis and Health
President Trump recently loosened federal medical‑marijuana restrictions, prompting optimism among researchers for expanded studies. The FDA currently approves only a few cannabis‑derived drugs for chemotherapy‑induced nausea, AIDS‑related wasting, and seizures. Experts highlight that the strongest evidence supports modest pain relief,...
What to Know About Orphines, a New Class of Deadly Opioids
Orphines, a synthetic opioid class up to ten times more potent than fentanyl, have surfaced in U.S. street drugs since late 2023. They evade standard toxicology screens, making overdoses harder to detect and treat. By May 2026 they were identified...
The AI Knowledge Gap We Can’t Afford to Ignore
Healthcare is rapidly integrating artificial intelligence, with two‑thirds of physicians using AI tools in 2024—a 78% surge from previous years. While AI can streamline chart review and surface clinical trends, experts warn that overreliance creates automation bias, magnifying documentation flaws...
What Is Your AI Drug Repurposing Strategy Missing?
The article argues that AI‑driven drug repurposing for oncology often fails because models are fed fragmented, noisy data despite abundant datasets. It stresses that more data alone won’t improve outcomes; instead, high‑quality, curated, structured data—such as knowledge graphs linking genes,...
A Study Of 4 Million People Points To A Surprising Brain Health Predictor
A meta‑analysis of 27 cohort studies covering more than 4 million participants found that higher cardiorespiratory fitness, measured by VO₂ max, is associated with a 36 % lower risk of depression and a 39 % lower risk of dementia. The relationship held even when...
HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
The Health and Human Services Department, led by Robert F. Kennedy Jr., is threatening to withhold Medicare and Medicaid payments from hospitals that serve sugary drinks or meals that fall short of the USDA’s 2025‑30 dietary guidelines. HHS issued a...
EU Backs Itvisma Gene Therapy for Spinal Muscular Atrophy
European regulators have issued a positive opinion on Itvisma, Novartis' onasemnogene abeparvovec gene therapy for spinal muscular atrophy (SMA). The Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorisation on 23 April 2026, pending final approval by the European Commission....
How Health Systems Are Tackling 'Kill the Clipboard' Obstacles
In July 2025, more than 60 health systems pledged to CMS to eliminate repetitive patient data entry, a move dubbed “Kill the Clipboard.” The initiative encourages patients to retrieve records from CMS Aligned Networks or personal health‑record apps and share...
Preparing for the 2026 HIPAA Changes: A Practical Guide for Healthcare Leaders
The Department of Health and Human Services will finalize a major overhaul of the HIPAA Security Rule in 2026, turning many previously optional safeguards into mandatory requirements. Organizations will face a tight compliance window—potentially as short as 60 days—once the...
What’s Next for Post-Acute Care: Data, Collaboration and the Path Forward
Post‑acute care is moving from a peripheral concern to a core pillar of health‑plan strategy. Plans are replacing delayed claims with real‑time clinical data, fostering tighter collaboration across hospitals and post‑acute providers, and embracing value‑based payment models that tie reimbursement...
Vantrexa Sets High Standards for Retatrutide Research Materials in Metabolic Studies
Vantrexa, a professional laboratory supplier, is now offering research‑grade Retatrutide (LY3437943), a triple‑agonist targeting GLP‑1, GIP and glucagon receptors, for metabolic studies. The company employs advanced solid‑phase peptide synthesis and rigorous in‑house plus third‑party HPLC/LC‑MS testing, achieving purity levels above...
White House Says It's Cut VA Wait Times, but New Study Paints More Complicated Picture
The White House touts reduced VA wait times after the Trump administration cut roughly 30,000 VA jobs, but a Vet Voice Foundation study of 21 VA medical centers shows wait times rose at 71% of sites and in 64% of...
Rhythm Pharmaceuticals Reports the EC Approval of Imcivree (Setmelanotide) for Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals announced that the European Commission has granted marketing authorization for Imcivree (setmelanotide) to treat acquired hypothalamic obesity in patients aged four years and older. The approval is based on the Phase III TRANSCEND trial, which enrolled 120 participants...
Novo Nordisk to Launch Ozempic for Type 2 Diabetes in US
Novo Nordisk will launch an oral version of Ozempic in the United States, following FDA approval that marks the first oral GLP‑1 drug cleared for both blood‑sugar control and cardiovascular risk reduction. The tablets, available in 1.5 mg, 4 mg and 9 mg...
High-Intensity Interval Training Shows Strongest Vascular Benefits in Cardiovascular Patients
Researchers at Miguel Hernández University and ISABIAL conducted a systematic review and network meta‑analysis of 37 trials involving 6,818 patients with coronary artery disease or chronic heart failure. The analysis found high‑intensity interval exercise (HIIE) produced the largest gains in...
Independent Evidence Reviews Overturn Insurer Denials Of Healthcare Coverage
Independent clinical reviewers in New York reversed nearly half of health‑insurance claim denials between 2019 and 2025, with 80% of appealed cases resulting in coverage. The findings highlight systemic flaws in prior‑authorization processes that generate millions of denials annually across...
Arvinas and Pfizer Report the US FDA Approval of Veppanu (Vepdegestrant) for ESR1-Mutated Breast Cancer
The U.S. FDA has approved Veppanu (vepdegestrant) for adults with ESR1‑mutated ER+/HER2‑ advanced or metastatic breast cancer who have received at least one line of endocrine therapy. The approval follows the Phase III VERITAC‑2 trial, which compared Veppanu to fulvestrant...
Joint Call by the President of the ICRC, the Director-General of WHO and the International President of MSF
The International Committee of the Red Cross, World Health Organization and Médecins Sans Frontières jointly warned that UN Security Council Resolution 2286, adopted a decade ago to protect health care in armed conflict, has failed as attacks on hospitals, ambulances and...
65 % of Eligible Lung Cancer Patients Do Not Receive the Most Appropriate Targeted Therapies, Diaceutics Report Finds
Diaceutics’ 2026 Clinical Practice Gaps report shows that 65% of U.S. patients with advanced non‑small cell lung cancer still miss the most appropriate targeted therapy, a figure unchanged since 2019. While biomarker testing has improved, the biggest loss now occurs...
AAD Survey Reveals Americans Ignore Sun Risks Despite Skin Cancer Concerns
The American Academy of Dermatology’s 2026 Practice Safe Sun Survey reveals a stark gap between perceived and actual sun‑protection habits. Although 57 % of Americans say they use sunscreen regularly, one‑third reported a sunburn in the past year and nearly half...
How Can Care Homes Charge Fees After a Death?
Avery Healthcare, which runs over 100 UK care homes, has re‑introduced contract clauses that charge families for up to 14 days after a resident’s death and demand an upfront £595 (~$756) dilapidation fee. These provisions clash with the Competition and...
A Decade After the ‘Godfather of AI’ Said Radiologists Were Obsolete, Their Salaries Are up to $571K and Demand Is...
Ten years after Geoffrey Hinton warned that AI would make radiologists obsolete, the specialty is thriving. The U.S. radiology workforce grew about 10%, while average compensation rose to $571,000 in 2025, a 9% increase year‑over‑year. Demand remains high, with over...
Artificial Retina Uses Biological Liquid Medium for Direct-to-Display ‘Vision’
Italian researchers led by Prof. Thomas M. Brown unveiled BIOPIX, a bio‑electronic hybrid retina emulator that embeds organic photodetectors in a liquid Ames medium. The proof‑of‑concept includes a 2 × 2 cone‑type array for colour and a 4 × 4 rod‑type array for grayscale,...